Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03681015 · ClinicalTrials.gov registry record
Wearable Assessments in the Clinic and Home in PD
A clinical trial of Parkinson Disease, sponsored by University of Rochester.
- Completed
- Registry status
- 132
- Enrollment target
- 17
- Study locations
NCT03681015 is a study of Parkinson Disease that has completed, run by University of Rochester. The registered enrollment target is 132 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 17 study locations across 13 states.
The verdict
NCT03681015, a study of Parkinson Disease, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
- 17
- Study locations
Study Summary
The purpose of this study is to evaluate disease progression in persons with early Parkinson disease, as assessed by digital and electronic sensor data collection to be correlated with typical clinical assessments.
Conditions Studied
Study Locations (17)
New York
- Northwell Health - Great Neck
- NYU Langone Health - New York
- University of Rochester - Rochester
Ohio
- University of Cincinnati - Cincinnati
- University Hospitals Cleveland Medical Center - Cleveland
Virginia
- Virginia Commonwealth University - Richmond
- Sentara Clinical Research - Virginia Beach
Arizona
- Banner Sun Research Institute - Sun City
California
- University of California San Francisco - San Francisco
Colorado
- University of Colorado Denver - Aurora
Florida
- University of South Florida - Tampa
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2019-04-24 |
| Est. Completion | 2022-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03681015
The ClinicalTrials.gov registry entry for NCT03681015 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03681015 reports 17 study locations spanning 13 distinct geographic areas - top geographies include New York, Ohio, Virginia.
Frequently Asked Questions
What is clinical trial NCT03681015 about?
NCT03681015 is a clinical study titled "Wearable Assessments in the Clinic and Home in PD". The purpose of this study is to evaluate disease progression in persons with early Parkinson disease, as assessed by digital and electronic sensor data collection to be correlated with typical clinical assessments.
What is the current status of trial NCT03681015?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2019-04-24. Estimated completion is 2022-03-30.
What conditions does trial NCT03681015 study?
This clinical trial studies the following conditions: Parkinson Disease.
Who is sponsoring clinical trial NCT03681015?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03681015 being conducted?
This trial has 17 study locations across Arizona, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.